🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsLab Results & BiomarkersOptimal lab testing frequency on GLP-1 — evidence-based schedule

Optimal lab testing frequency on GLP-1 — evidence-based schedule

Dr.Martinez Mon, Jun 8, 2026 at 5:52 PM 5 replies 55 viewsPage 1 of 1
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Jun 8, 2026 at 5:52 PM#1

A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about the baseline and follow-up panel, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin and B12, and a full blood count. That set catches the things that change, the things that explain symptoms, and the things that alter the prescribing decision. Almost everything else on the long circulating lists is either invariant, uninterpretable without a specific question, or an incidental finding waiting to cause an unnecessary workup.

The condition it depends on

Reference ranges are laboratory-specific. Comparing your number to somebody else's range, or to a screenshot from another country, is how people convince themselves something is wrong.

The practical version

Post reference ranges alongside numbers when you share them. Units differ by country — glucose and lipids especially — and half the confusion in these threads is unit mismatch rather than disagreement.

What I am not sure about

So the question, as narrowly as I can put it: how often to repeat it, because quarterly seems to be the convention and I cannot find the reasoning. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

— Dr.Martinez · corrections welcome and will be edited into this post with credit
8 11AttorneyGrant, DebRD_ATL, KristenIndy and 5 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 8, 2026 at 6:12 PM#2
Dr.Martinez said:
A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin…

That is correct as far as it goes, and here is where it stops going. The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value. One out-of-range result in isolation generates anxiety and unnecessary tests; the same result next to the trend and the rest of the panel usually generates a shrug.

Last edited: Jun 8, 2026 at 7:12 PM
9 12mike_nyc, VendorMark, COA_Karl and 6 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jun 8, 2026 at 6:32 PM#3
Dr.Martinez said:
A defensible baseline is short: HbA1c and fasting glucose, a lipid panel with ApoB if you can get it, ALT and AST, creatinine with eGFR, TSH, ferritin…

Pushing back on Dr.Martinez here. I would drop the "get everything" instinct further than this thread does. Every extra test is another chance at a false positive, and incidental findings have their own cost in scans, biopsies and worry.

Last edited: Jun 8, 2026 at 10:32 PM
10 13BrianDallas92, labquiet_amy, emily_PDX and 7 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Jun 8, 2026 at 6:52 PM#4

Answering the narrow version, because the broad one does not have a single answer. Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c becomes informative again, since it reflects about three months of glycaemia. After the first year, and once doses are stable, annual is reasonable unless something specific is being followed.

Last edited: Jun 8, 2026 at 11:52 PM
11 14pete_nash, hank_denver, carlos_SATX and 8 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jun 8, 2026 at 8:39 PM#5
DataDave said:
The single most useful discipline is bringing the whole panel to a clinician rather than one flagged value.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

Last edited: Jun 8, 2026 at 9:39 PM
12 15NicoleRaleigh, james_edin, FranDenver and 9 others
Reply Quote Save Share Report

Similar Threads

A1C from 7.2 to 5.1 — my bloodwork transformation19 replies
Thyroid function monitoring on GLP-1 — TSH and free T4 trends3 replies
Lipid panel improvements mega-thread — share your numbers19 replies
Liver enzymes trending down on GLP-1 — ALT/AST normalization17 replies
Kidney function on semaglutide — eGFR and UACR improvements21 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register